Divi’s, Gland, Fidelity enter race to buy Orchid Pharma

The move comes even as Divi’s Laboratories, Gland Celsus Bio Chemicals and Fidelity Trading Corporation have evinced interest to take over cephalosporin drugmaker.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2VuvxeH
via IFTTT